News

From the lab to commercialization of research: a multi-discovery path

Montreal, December 7, 2018 – For the course BIM 6070 « Pratique professionnelle de la recherche », Nadine Beauger, Chief Executive Officer, IRICoR, will pronounce the conference entitled: From the lab to commercialization of research: a multi-discovery path.

 
BIM 6070 introduces students to the scientific method in research and to the experimental approach. Furthermore, this course initiates them to: the process of […]

Steven Klein, guest speaker at the 7th edition of BioFIT

As part of the 7th edition of BioFIT, held December 4th and 5th, in Lille, Steven Klein, Vice President, Business Development at IRICoR, will take part in a discussion session as a guest speaker. Along with Mr. Michael Salgaller from the National Institutes of Health (NIH) and Mme Hélène Peyro-Saint-Paul from LallianSE Entrepreneurs, Steven will discuss the recent initiatives implemented […]

IRICoR to attend BIO-Europe 2018

IRICoR participates for the eighth consecutive year at the 24rd Annual International Partnering Conference BIO-Europe. This conference is held from November 5 to November 7, 2018 at the Bella Center in Copenhagen, Danemark. This industry event aims to create business opportunities between life science players from around the world. It is also an opportunity for companies and institutions to develop partnerships of interest […]

10 years of success in drug discovery and renewed funding from governments

Montreal, October 24, 2018 – IRICoR celebrated, on Monday, 10 years of success in drug discovery and renewed funding from governments. For the occasion, we had a very interesting panel on artificial intelligence and drug discovery which led to a rich discussion between our four panelists: Pierre Côte, Therence Bois, Sébastien Lemieux and Jean-Sébastien Cournoyer. A real success!
Thanks to […]

IRICoR to present at the LES workshop – Montreal Chapter

Laval, October 09, 2018 – Dr. Steven Klein, Vice-President Business Development at IRICoR is a guest speaker today,  at the Licensing Executives Society workshop to held at Servier canada inc.
The conference will be entitled “Biotechnology & Pharma Companies: “Facing the challenges in oncology: The North American and French Perspective” »”. Oncology appears today as the most difficult challenging therapeutic area from both scientific […]

Symposium : Artificial Intelligence + Drug Discovery

On the next October 22, IRICoR invites you to participate in a roundtable featuring four leaders from research, business and industry who will share a new vision for generating the therapeutic solutions of tomorrow.
Speakers 

 

When: Monday, October 22, 2018 at 5 pm
Where: Agora Morris and Rosalind Goodman, Marcelle Coutu Pavilion

 
This will be followed by a cocktail celebrating 10 years of IRICoR’s […]

Invited speaker – International Congress on Personalized Health Care 2018

Nadine Beauger, Chief Executive Officer of IRICoR, participated, this Monday, to the 2nd edition of the International Congress on Personalized Health Care (ICPHC2018) organized by The Quebec Network for Personalized Health Care (QNPHC) to present the innovative business model of IRICoR at the « Innovative Technologies in “OMICS” Applications » session.
As Université de Montréal’s drug discovery and project […]

Launch of the LeadAction-Onco Competition

Montreal, September 20, 2018 – IRICoR is proud to launch, today with the Oncopole, this new LeadAction-Onco Competition. This joint call for projects, in partnership with the FRQS, is an opportunity for researchers from Quebec and the rest of Canada to accelerate the transformation of their projects in oncology and immuno-oncology into novel therapies […]

Nadine Beauger and Steven Klein look back on 10 years of success, in the magazine BioTechnology Focus

Dr. Nadine Beauger, Chief Executive Director and Dr. Steven Klein, Vice President, Business Development at IRCoR, took part in a Q&A session to discuss the key strengths and benefits of IRICoR’s model, its achievements and the partnerships created over the past 10 years, as well as the organization’s vision for the next 5 years, in the August-September 2018 edition of […]

IRICoR receives 25 million dollars to support its research commercialization activities as part of the 2018 CECR competition

Montreal, July 30, 2018 — IRICoR (Institute for Research in Immunology and Cancer – Commercialization of Research), a drug discovery and commercialization cluster, is proud to announce that it has received substantial support from the federal government in the amount of 25 million dollars, as part of the 2018 edition of the Centres of Excellence for Commercialization and Research program […]

« Previous Page | Next Page »